Day: November 3, 2020

CAMBRIDGE, United Kingdom, Nov. 03, 2020 (GLOBE NEWSWIRE) — Abcam plc (AIM: ABC) (Nasdaq: ABCM), a global leader in the supply of life science research tools, announces that, following release on 14 September 2020 of its final results for the year ended 30 June 2020, the Abcam plc Annual Report and Accounts 2020 (the “Annual Report”) have been published today and are available on the Abcam plc website at www.abcamplc.com.A copy of the Annual Report has been submitted to the National Storage Mechanism and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.The Annual Report will also be posted today, together with the Notice of Annual General Meeting, to those shareholders that have elected to receive paper communications.  Shareholders that have not elected to receive paper communications...

Full enrollment of 195 subjects in NORSE THREE achieved in less than one month, significantly ahead of scheduleAll planned clinical trials for ONS-5010/LYTENAVA™ BLA for wet AMD now fully enrolled or completedPivotal data expected in mid-2021 from ongoing, fully enrolled Phase 3 registration trial for ONS-5010 (NORSE TWO) with new BLA filing expected in second half of 2021MONMOUTH JUNCTION, N.J., Nov. 03, 2020 (GLOBE NEWSWIRE) — Outlook Therapeutics, Inc. (Nasdaq: OTLK), a late clinical-stage biopharmaceutical company working to develop the first FDA-approved ophthalmic formulation of bevacizumab-vikg for use in retinal indications, today announced the completion of patient enrollment for its planned open-label safety study evaluating ONS-5010/LYTENAVA™ (NORSE THREE). Patient enrollment for the study was completed in less than one...

HOUSTON, Nov. 03, 2020 (GLOBE NEWSWIRE) — Recruiter.com Group, Inc. (OTCQB: RCRT), a leading AI-powered hiring platform with the world’s largest network of recruiters, has announced eight new client wins in the healthcare industry, from which Recruiter.com could generate more than $8 million of revenue over the next 14 months.A recent Recruiter Index® report showed optimism in the healthcare sector, with 80 percent of surveyed recruiters expecting demand to increase in the vertical through the end of the year. As reported by Medical Economics on October 5, 2020, the U.S. added 53,000 healthcare jobs in September and 75,300 in August.“Of the new jobs added to the Recruiter.com Job Market platform, approximately 34% are in healthcare,” said Evan Sohn, CEO of Recruiter.com. “These represent great career opportunities...

New York, NY, Nov. 03, 2020 (GLOBE NEWSWIRE) — Legacy Acquisition Corp. (NYSE: “LGC”) (“Legacy”), a publicly-traded special purpose acquisition company, announced today that it has extended the expiration date of its previously announced tender offer to purchase up to all of its 6,122,699 issued and outstanding shares of Class A common stock, par value $0.0001 per share (“Class A Common Stock”), that were initially issued as part of the units in its initial public offering (such shares of Class A common stock, the “Public Shares”) at a price of $10.5040 per Public Share, net to the seller in cash, without interest (the “Purchase Price”). This Offer is being made in accordance with the provisions of the previously announced Business Combination Agreement, dated September 18, 2020, by and among Legacy, Excel Merger Sub I, Inc, Excel...

YERINGTON, Nev., Nov. 03, 2020 (GLOBE NEWSWIRE) — Nevada Copper Corp. (TSX: NCU) (“Nevada Copper” or the “Company’’) provides an operations update, including October production and progress with completion of the Main Shaft at its Pumpkin Hollow Underground Mine.Mike Ciricillo, Chief Executive Officer of Nevada Copper, stated:“We are pleased that the Main Shaft steelwork is complete and that work is progressing on the materials handling system. In the meantime, we continue to hoist development ore via the East North Vent Shaft and look forward to our continued ramp–up to 5,000 tpd. We are also pleased that our lateral development rates are on schedule with development ore grades continuing to increase to targeted levels. Mill ramp up continues positively with extended periods of operation approaching nameplate throughput and...

SOUTH SAN FRANCISCO, Calif., Nov. 03, 2020 (GLOBE NEWSWIRE) — Catalyst Biosciences, Inc. (NASDAQ: CBIO) today announced that Nassim Usman, Ph.D., president and chief executive officer, and Clinton Musil, chief financial officer, of Catalyst Biosciences will present at the Stifel 2020 Virtual Healthcare Conference taking place on November 16-18, 2020. Details for the company presentation are as follows:An archived webcast of the presentation will be available for 90 days on the Events and Presentations section on the Company’s website.About Catalyst BiosciencesCatalyst is a research and clinical development biopharmaceutical company focused on addressing unmet medical needs in rare hematologic and complement-mediated disorders. Our protease engineering platform generated two late-stage clinical programs in hemophilia; a research...